Abstract
Purpose
Delivery of siRNA into cells remains a critical challenge. Our lab has shown a novel polyamidoamine (PAMAM) dendrimer with modified pentaerythritol derivative core (PD dendrimer) to exhibit high plasmid DNA transfection efficiency and low cytotoxicity. Here, we evaluate PD dendrimer as a siRNA carrier.
Methods
Agarose gel electrophoresis and AFM were used to confirm formation of generation 5 (G5)-PD dendrimer/siRNA nanoparticles (NPs). G5 PD dendrimer/anti-luciferase siRNA NPs were used to transfect SK Hep-1 cells with stable luciferase expression. Effects of various endocytic pathway inhibitors on uptake of G5 PD dendrimer/siRNA NPs in SK Hep-1 cells were also investigated.
Results
Agarose gel electrophoresis indicated that G5 PD dendrimer and siRNA formed NPs at weight ratios >0.5:1. G5 PD dendrimer showed effective luciferase gene silencing when weight ratio was 3.0:1 and above. Treatment with endocytosis inhibitors showed that clathrin-mediated endocytosis was the main endocytic pathway by which G5-PD dendrimer/siRNA NPs enter the cell.
Conclusions
These results show that the novel G5 PD dendrimer has high siRNA delivery activity and is promising as a delivery agent for its therapeutic application.
Similar content being viewed by others
REFERENCES
E. A. E. AK. Insight-RNA Interference. Nature 431: (2004).
Huang Y, Chen J, Chen X, Gao J, Liang W. PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides. J Mater Sci Mater Med. 2008;19:607–14.
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–11.
Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit J-P. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials. 2008;29:3477–96.
Zhang S, Zhao B, Jiang H, Wang B, Ma B. Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release. 2007;123:1–10.
Svensonand S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Adv Drug Deliv Rev. 2005;57:2106–29.
Ohsaki M, Okuda T, Wada A, Hirayama T, Niidome T, Aoyagi H. In Vitro Gene Transfection Using Dendritic Poly(l-lysine). Bioconjug Chem. 2002;13:510–7.
Patil ML, Zhang M, Taratula O, Garbuzenko OB, He H, Minko T. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. Biomacromolecules. 2009;10:258–66.
Kim HK, Davaa E, Myung CS, Park JS. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Int J Pharm. 2010;392:141–7.
J. Zhou, J. Wu, N. Hafdi, J.-P. Behr, P. Erbacher, and L. Peng. PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Comm. 2006;22:2362–4.
Patil ML, Zhang M, Betigeri S, Taratula O, He H, Minko T. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjug Chem. 2008;19:1396–403.
Wang Y, Kong W, Song Y, Duan Y, Wang L, Steinhoff G, Kong D, Yu Y. Polyamidoamine dendrimers with a modified pentaerythritol core having high efficiency and low cytotoxicity as gene carriers. Biomacromolecules. 2009;10:617–22.
Zhou C, Yu B, Yang X, Huo T, Lee LJ, Barth RF, Lee RJ. Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery. Int J Pharm. 2010;392:201–8.
C. Zhou, Y. Mao, Y. Sugimoto, Y. Zhang, N. Kanthamnen, B. Yu, R. Brueggemeier, L. J. Lee, and R. J. Lee. SPANosomes as delivery vehicles for small interfering RNA (siRNA). Mol Pharm, doi:10.1021/mp200426h (Accepted).
Khalil IA, Kogure K, Akita H, Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev. 2006;58:32–45.
Killisch I, Steinlein P, Romisch K, Hollinshead R, Beug H, Griffiths G. Characterization of early and late endocytic compartments of the transferrin cycle. Transferrin receptor antibody blocks erythroid differentiation by trapping the receptor in the early endosome. J Cell Sci. 1992;103:211–32.
Lencer WI, Hirst TR, Holmes RK. Membrane traffic and the cellular uptake of cholera toxin. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research. 1999;1450:177–90.
Chuand JJH, Ng ML. Infectious entry of west Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol. 2004;78:10543–55.
Kruth HS, Jones NL, Huang W, Zhao B, Ishii I, Chang J, Combs CA, Malide D, Zhang W-Y. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J Biol Chem. 2005;280:2352–60.
Nabiand IR, Le PU. Caveolae/raft-dependent endocytosis. J Cell Biol. 2003;161:673–7.
Tyagiand S, Kramer FR. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol. 1996;14:303–8.
Boukany PE, Morss A, Liao WC, Henslee B, Jung H, Zhang X, Yu B, Wang X, Wu Y, Li L, Gao K, Hu X, Zhao X, Hemminger O, Lu W, Lafyatis GP, Lee LJ. Nanochannel electroporation delivers precise amounts of biomolecules into living cells. Nat Nanotechnol. 2011;6:747–54.
C. Zhou, L. J. Lee, and R. J. Lee. Cellular pharmacokinetics (PK) and target gene knockdown of surfactant- and lipid-based nanocarriers (NCs) of siRNA. AAPS J 13: Abstract W3028 (2011).
Waiteand CL, Roth CM. PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma. Bioconjug Chem. 2009;20:1908–16.
Kang H, DeLong R, Fisher M, Juliano R. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. Pharm Res. 2005;22:2099–106.
ACKNOWLEDGMENTS & DISCLOSURES
This research was supported by Natural Science Foundation of China (No. 50803029), NIH grant R01CA135243, and NSF grant EEC-0425626 to R. Lee.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Yue Zhang and Chenguang Zhou contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Esm 1
(DOC 3629 kb)
Rights and permissions
About this article
Cite this article
Zhang, Y., Zhou, C., Kwak, K.J. et al. Efficient siRNA Delivery Using a Polyamidoamine Dendrimer with a Modified Pentaerythritol Core. Pharm Res 29, 1627–1636 (2012). https://doi.org/10.1007/s11095-012-0676-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-012-0676-x